213 related articles for article (PubMed ID: 20825282)
1. Retroviral and transposon-based tet-regulated all-in-one vectors with reduced background expression and improved dynamic range.
Heinz N; Schambach A; Galla M; Maetzig T; Baum C; Loew R; Schiedlmeier B
Hum Gene Ther; 2011 Feb; 22(2):166-76. PubMed ID: 20825282
[TBL] [Abstract][Full Text] [Related]
2. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
[TBL] [Abstract][Full Text] [Related]
3. Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors.
Schmeisser F; Donohue M; Weir JP
Hum Gene Ther; 2002 Dec; 13(18):2113-24. PubMed ID: 12542843
[TBL] [Abstract][Full Text] [Related]
4. The tet-off system is more effective than the tet-on system for regulating transgene expression in a single adenovirus vector.
Mizuguchi H; Hayakawa T
J Gene Med; 2002; 4(3):240-7. PubMed ID: 12112641
[TBL] [Abstract][Full Text] [Related]
5. Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions.
Mizuguchi H; Xu ZL; Sakurai F; Mayumi T; Hayakawa T
Hum Gene Ther; 2003 Sep; 14(13):1265-77. PubMed ID: 12952598
[TBL] [Abstract][Full Text] [Related]
6. Retroviral vectors for high-level transgene expression in T lymphocytes.
Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
[TBL] [Abstract][Full Text] [Related]
7. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells.
Paulus W; Baur I; Boyce FM; Breakefield XO; Reeves SA
J Virol; 1996 Jan; 70(1):62-7. PubMed ID: 8523582
[TBL] [Abstract][Full Text] [Related]
8. Tetracycline-inducible transgene expression mediated by a single AAV vector.
Chtarto A; Bender HU; Hanemann CO; Kemp T; Lehtonen E; Levivier M; Brotchi J; Velu T; Tenenbaum L
Gene Ther; 2003 Jan; 10(1):84-94. PubMed ID: 12525840
[TBL] [Abstract][Full Text] [Related]
9. Stringent and reproducible tetracycline-regulated transgene expression by site-specific insertion at chromosomal loci with pre-characterised induction characteristics.
Brough R; Papanastasiou AM; Porter AC
BMC Mol Biol; 2007 May; 8():30. PubMed ID: 17493262
[TBL] [Abstract][Full Text] [Related]
10. Versatile retrovirus vector systems for regulated gene expression in vitro and in vivo.
Lindemann D; Patriquin E; Feng S; Mulligan RC
Mol Med; 1997 Jul; 3(7):466-76. PubMed ID: 9260158
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vector system for coordinated constitutive and drug controlled tetracycline-regulated gene co-expression.
Stahlhut M; Schwarzer A; Eder M; Yang M; Li Z; Morgan M; Schambach A; Kustikova OS
Biomaterials; 2015 Sep; 63():189-201. PubMed ID: 26113075
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
[TBL] [Abstract][Full Text] [Related]
13. Improved applications of the tetracycline-regulated gene depletion system.
Nishijima H; Yasunari T; Nakayama T; Adachi N; Shibahara K
Biosci Trends; 2009 Oct; 3(5):161-7. PubMed ID: 20103842
[TBL] [Abstract][Full Text] [Related]
14. Development of a self-inactivating tet-on retroviral vector expressing bone morphogenetic protein 4 to achieve regulated bone formation.
Peng H; Usas A; Gearhart B; Young B; Olshanski A; Huard J
Mol Ther; 2004 Jun; 9(6):885-94. PubMed ID: 15194055
[TBL] [Abstract][Full Text] [Related]
15. The use of retroviral vectors for tet-regulated gene expression in cell populations.
Löw R
Methods Mol Biol; 2009; 506():221-42. PubMed ID: 19110630
[TBL] [Abstract][Full Text] [Related]
16. Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system.
A-Mohammadi S; Hawkins RE
Gene Ther; 1998 Jan; 5(1):76-84. PubMed ID: 9536267
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of adenovirus-mediated tetracycline-controllable expression system.
Mizuguchi H; Hayakawa T
Biochim Biophys Acta; 2001 Nov; 1568(1):21-9. PubMed ID: 11731081
[TBL] [Abstract][Full Text] [Related]
18. New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo.
Rubinchik S; Woraratanadharm J; Yu H; Dong JY
Gene Ther; 2005 Mar; 12(6):504-11. PubMed ID: 15660114
[TBL] [Abstract][Full Text] [Related]
19. An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy.
Sipo I; Hurtado Picó A; Wang X; Eberle J; Petersen I; Weger S; Poller W; Fechner H
J Mol Med (Berl); 2006 Mar; 84(3):215-25. PubMed ID: 16437213
[TBL] [Abstract][Full Text] [Related]
20. In vivo manipulation of interleukin-2 expression by a retroviral tetracycline (tet)-regulated system.
Pitzer C; Schindowski K; Pomer S; Wirth T; Zöller M
Cancer Gene Ther; 1999; 6(2):139-46. PubMed ID: 10195880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
